sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Exosome Diagnostic and Therapeutic Market by Application (Diagnostic and Therapeutic), Product (Instrument, Reagent and Software) and End-User (Cancer Institute, Hospital, Diagnostic Center, and Others) - Global Opportunity Analysis and Industry Forecasts, 2014-2022

Exosome Diagnostic and Therapeutic Market by Application (Diagnostic and Therapeutic),...

Home / Categories / Healthcare
Exosome Diagnostic and Therapeutic Market by Application (Diagnostic and Therapeutic), Product (Instrument, Reagent and Software) and End-User (Cancer Institute, Hospital, Diagnostic Center, and Others) - Global Opportunity Analysis and Industry Forecasts, 2014-2022
Exosome Diagnostic and Therapeutic Market...
Report Code
RO1/113/1063

Publish Date
01/Sep/2016

Pages
115
PRICE
$ 1800/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 2350/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 2850/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
CHAPTER 1 INTRODUCTION

1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 CXO perspective

CHAPTER 3 MARKET OVERVIEW

3.1 Market definition and scope

3.1.1 Top investment pockets
3.1.2 Top winning strategies

3.2 Porters Five Forces analysis

3.2.1 Bargaining power of the suppliers
3.2.2 Bargaining power of buyers
3.2.3 Threat of new entrants
3.2.4 Intensity of rivalry
3.2.5 Threat of substitutes

3.3 Market dynamics

3.3.1 Drivers

3.3.1.1 increasing prevalence of cancer
3.3.1.2 initiatives implemented by the government and non-government associations for rise in health awareness
3.3.1.3 technological advancements in exosomes isolation and analytical procedures
3.3.1.4 Innovative and advanced Applications of exosomes

3.3.2 Restraints

3.3.2.1 Technical difficulties in the usage of exosomes
3.3.2.2 Stringent regulatory requirements for the approval and commercialization of Exosome diagnostic and therapeutic products
3.3.2.3 low awareness and lack of skilled professionals required for the isolation of exosomes

3.3.3 Opportunities

3.3.3.1 developing economies offer lucarative growth opportunities

CHAPTER 4 WORLD EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET, BY APPLICATION

4.1 Overview
4.2 Diagnostic application

4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast

4.3 Therapeutic application

4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast

CHAPTER 5 WORLD EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET, BY PRODUCT

5.1 Overview
5.2 Instrument

5.2.1 Key market trends
5.2.2 Key growth factors and opportunities
5.2.3 Market size and forecast

5.3 Reagents

5.3.1 Key market trends
5.3.2 Key growth factors and opportunities
5.3.3 Market size and forecast

5.4 Software

5.4.1 Key market trends
5.4.2 Key growth factors and opportunities
5.4.3 Market size and forecast

CHAPTER 6 WORLD EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET, BY END USER

6.1 Overview

6.1.1 Market size and forecast

6.2 Cancer Institutes

6.2.1 Market size and forecast

6.3 Hospitals

6.3.1 Market size and forecast

6.4 Diagnostic Centers

6.4.1 Market size and forecast

6.5 Others

6.5.1 Market size and forecast

CHAPTER 7 WORLD EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET, BY GEOGRAPHY, 2015-2022

7.1 Overview

7.1.1 Market size and forecast

7.2 North America

7.2.1 Key market trends
7.2.2 Key growth factors and opportunities
7.2.3 Market size and forecast
7.2.4 U.S.: market size and forecast
7.2.5 Canada market size and forecast
7.2.6 Mexico: market size and forecast

7.3 Europe

7.3.1 Key market trends
7.3.2 Key growth factors and opportunities
7.3.3 Market size and forecast
7.3.4 Germany: market size and forecast
7.3.5 France: market size and forecast
7.3.6 U.K.: market size and forecast
7.3.7 Italy market size and forecast
7.3.8 Rest of Europe: market size and forecast

7.4 Asia-Pacific

7.4.1 Key market trends
7.4.2 Key growth factors and opportunities
7.4.3 Market size and forecast
7.4.4 Japan: market size and forecast
7.4.5 China market size and forecast
7.4.6 Rest of Asia-Pacific: market size and forecast

7.5 LAMEA

7.5.1 Key market trends
7.5.2 Key growth factors and opportunities
7.5.3 Market size and forecast

CHAPTER 8 COMPANY PROFILES

8.1 Aethlon Medical, Inc.

8.1.1 Company overview
8.1.2 Operating business segments
8.1.3 Business performance
8.1.4 Key strategic moves & developments

8.2 Exosome Diagnostics, Inc.

8.2.1 Company overview
8.2.2 Operating business segments
8.2.3 Business performance
8.2.4 Key strategic moves & developments

8.3 NanoSomix, Inc.

8.3.1 Company overview
8.3.2 Operating business segments
8.3.3 Business performance
8.3.4 Key strategic moves & developments

8.4 Thermo Fisher Scientific, Inc.

8.4.1 Company overview
8.4.2 Operating business segments
8.4.3 Business performance
8.4.4 Key strategic moves & developments

8.5 Malvern Instruments Ltd

8.5.1 Company overview
8.5.2 Operating business segments
8.5.3 Business performance
8.5.4 Key strategic moves & developments

8.6 System Biosciences, Inc.

8.6.1 Company overview
8.6.2 Operating business segments
8.6.3 Business performance
8.6.4 Key strategic moves & developments

8.7 NX PHARMAGEN

8.7.1 Company overview
8.7.2 Operating business segments
8.7.3 Business performance
8.7.4 Key strategic moves & developments

8.8 Sistemic Ltd.

8.8.1 Company overview
8.8.2 Operating business segments
8.8.3 Business performance
8.8.4 Key strategic moves & developments

8.9 Capricor Therapeutics, Inc.

8.9.1 Company overview
8.9.2 Operating business segments
8.9.3 Business performance
8.9.4 Key strategic moves & developments

8.10 Exiqon A/S

8.10.1 Company overview
8.10.2 Operating business segments
8.10.3 Business performance
8.10.4 Key strategic moves & developments

*Other players in the value chain include (players not profiled in the report)

101BIO
AMS Biotechnology Limited
Therapeutic Solutions International, Inc.
ReNeuron Group plc
Immune Therapy Holdings AB
ExoCyte Therapeutics Pte Ltd
Cell Guidance Systems LLC
BioRegenerative Sciences, Inc.
Evomic Science LLC
Norgen Biotek Corp.

*Profiles of these players are not included. The same will be included on request

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com